Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease

Abstract Background Identifying modifiable risk factors for cognitive impairment in the early stages of Parkinson’s disease (PD) and estimating their impact on cognitive status may help prevent dementia (PDD) and the design of cognitive trials. Methods Using a standard approach for the assessment of...

Full description

Bibliographic Details
Main Authors: Saul Martínez-Horta, Helena Bejr-Kasem, Andrea Horta-Barba, Berta Pascual-Sedano, Diego Santos-García, Teresa de Deus-Fonticoba, Silvia Jesús, Miquel Aguilar, Lluis Planellas, Juan García-Caldentey, Nuria Caballol, Bárbara Vives-Pastor, Jorge Hernández-Vara, Iria Cabo-Lopez, Lydia López-Manzanares, Isabel González-Aramburu, Maria Asunción Ávila-Rivera, Maria Jose Catalán, Luis Manuel López-Díaz, Victor Puente, Jose Manuel García-Moreno, Carmen Borrué, Berta Solano-Vila, Maria Álvarez-Sauco, Lydia Vela, Sonia Escalante, Esther Cubo, Francisco Carrillo-Padilla, Juan Carlos Martínez-Castrillo, Pilar Sánchez-Alonso, Maria Gema Alonso-Losada, Nuria López-Ariztegui, Itziar Gastón, Marta Blázquez-Estrada, Manual Seijo-Martínez, Javier Rúiz-Martínez, Caridad Valero-Merino, Monica Kurtis, Oriol de Fábregues-Boixar, Jessica González-Ardura, Cristina Prieto-Jurczynska, Pablo Martinez-Martin, Pablo Mir, Jaime Kulisevsky, COPPADIS Study Group
Format: Article
Language:English
Published: BMC 2021-12-01
Series:BMC Neurology
Subjects:
Online Access:https://doi.org/10.1186/s12883-021-02485-1
_version_ 1818462091814633472
author Saul Martínez-Horta
Helena Bejr-Kasem
Andrea Horta-Barba
Berta Pascual-Sedano
Diego Santos-García
Teresa de Deus-Fonticoba
Silvia Jesús
Miquel Aguilar
Lluis Planellas
Juan García-Caldentey
Nuria Caballol
Bárbara Vives-Pastor
Jorge Hernández-Vara
Iria Cabo-Lopez
Lydia López-Manzanares
Isabel González-Aramburu
Maria Asunción Ávila-Rivera
Maria Jose Catalán
Luis Manuel López-Díaz
Victor Puente
Jose Manuel García-Moreno
Carmen Borrué
Berta Solano-Vila
Maria Álvarez-Sauco
Lydia Vela
Sonia Escalante
Esther Cubo
Francisco Carrillo-Padilla
Juan Carlos Martínez-Castrillo
Pilar Sánchez-Alonso
Maria Gema Alonso-Losada
Nuria López-Ariztegui
Itziar Gastón
Marta Blázquez-Estrada
Manual Seijo-Martínez
Javier Rúiz-Martínez
Caridad Valero-Merino
Monica Kurtis
Oriol de Fábregues-Boixar
Jessica González-Ardura
Cristina Prieto-Jurczynska
Pablo Martinez-Martin
Pablo Mir
Jaime Kulisevsky
COPPADIS Study Group
author_facet Saul Martínez-Horta
Helena Bejr-Kasem
Andrea Horta-Barba
Berta Pascual-Sedano
Diego Santos-García
Teresa de Deus-Fonticoba
Silvia Jesús
Miquel Aguilar
Lluis Planellas
Juan García-Caldentey
Nuria Caballol
Bárbara Vives-Pastor
Jorge Hernández-Vara
Iria Cabo-Lopez
Lydia López-Manzanares
Isabel González-Aramburu
Maria Asunción Ávila-Rivera
Maria Jose Catalán
Luis Manuel López-Díaz
Victor Puente
Jose Manuel García-Moreno
Carmen Borrué
Berta Solano-Vila
Maria Álvarez-Sauco
Lydia Vela
Sonia Escalante
Esther Cubo
Francisco Carrillo-Padilla
Juan Carlos Martínez-Castrillo
Pilar Sánchez-Alonso
Maria Gema Alonso-Losada
Nuria López-Ariztegui
Itziar Gastón
Marta Blázquez-Estrada
Manual Seijo-Martínez
Javier Rúiz-Martínez
Caridad Valero-Merino
Monica Kurtis
Oriol de Fábregues-Boixar
Jessica González-Ardura
Cristina Prieto-Jurczynska
Pablo Martinez-Martin
Pablo Mir
Jaime Kulisevsky
COPPADIS Study Group
author_sort Saul Martínez-Horta
collection DOAJ
description Abstract Background Identifying modifiable risk factors for cognitive impairment in the early stages of Parkinson’s disease (PD) and estimating their impact on cognitive status may help prevent dementia (PDD) and the design of cognitive trials. Methods Using a standard approach for the assessment of global cognition in PD and controlling for the effects of age, education and disease duration, we explored the associations between cognitive status, comorbidities, metabolic variables and lifestyle variables in 533 PD participants from the COPPADIS study. Results Among the overall sample, 21% of participants were classified as PD-MCI (n = 114) and 4% as PDD (n = 26). The prevalence of hypertension, diabetes and dyslipidemia was significantly higher in cognitively impaired patients while no between-group differences were found for smoking, alcohol intake or use of supplementary vitamins. Better cognitive scores were significantly associated with regular physical exercise (p < 0.05) and cognitive stimulation (< 0.01). Cognitive performance was negatively associated with interleukin 2 (Il2) (p < 0.05), Il6 (p < 0.05), iron (p < 0.05), and homocysteine (p < 0.005) levels, and positively associated with vitamin B12 levels (p < 0.005). Conclusions We extend previous findings regarding the positive and negative influence of various comorbidities and lifestyle factors on cognitive status in early PD patients, and reinforce the need to identify and treat potentially modifiable variables with the intention of exploring the possible improvement of the global cognitive status of patients with PD.
first_indexed 2024-12-14T23:56:32Z
format Article
id doaj.art-0b9e0017c31e42568071f0f6b4ae9a90
institution Directory Open Access Journal
issn 1471-2377
language English
last_indexed 2024-12-14T23:56:32Z
publishDate 2021-12-01
publisher BMC
record_format Article
series BMC Neurology
spelling doaj.art-0b9e0017c31e42568071f0f6b4ae9a902022-12-21T22:43:06ZengBMCBMC Neurology1471-23772021-12-0121111010.1186/s12883-021-02485-1Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s diseaseSaul Martínez-Horta0Helena Bejr-Kasem1Andrea Horta-Barba2Berta Pascual-Sedano3Diego Santos-García4Teresa de Deus-Fonticoba5Silvia Jesús6Miquel Aguilar7Lluis Planellas8Juan García-Caldentey9Nuria Caballol10Bárbara Vives-Pastor11Jorge Hernández-Vara12Iria Cabo-Lopez13Lydia López-Manzanares14Isabel González-Aramburu15Maria Asunción Ávila-Rivera16Maria Jose Catalán17Luis Manuel López-Díaz18Victor Puente19Jose Manuel García-Moreno20Carmen Borrué21Berta Solano-Vila22Maria Álvarez-Sauco23Lydia Vela24Sonia Escalante25Esther Cubo26Francisco Carrillo-Padilla27Juan Carlos Martínez-Castrillo28Pilar Sánchez-Alonso29Maria Gema Alonso-Losada30Nuria López-Ariztegui31Itziar Gastón32Marta Blázquez-Estrada33Manual Seijo-Martínez34Javier Rúiz-Martínez35Caridad Valero-Merino36Monica Kurtis37Oriol de Fábregues-Boixar38Jessica González-Ardura39Cristina Prieto-Jurczynska40Pablo Martinez-Martin41Pablo Mir42Jaime Kulisevsky43COPPADIS Study GroupMovement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant PauMovement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant PauMovement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant PauMovement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant PauCHUAC, Complejo Hospitalario Universitario de A CoruñaComplejo Hospitalario Universitario de Ferrol (CHUF)Centro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED)Hospital Universitari Mutua de TerrassaHospital Clínic de BarcelonaHospital Quiron Palmaplanas, Clínica Rotger y Centro Neurológico Oms 42Consorci Sanitari Integral, Hospital Moisés Broggi, Sant Joan DespíHospital Universitario Son EspasesNeurology Department and Neurodegenerative Diseases Research GroupComplejo Hospitalario Universitario de Pontevedra (CHOP)Hospital La PrincesaHospital Universitario Marqués de ValdecillaConsorci Sanitari Integral, Hospital Moisés Broggi, Sant Joan DespíHospital Universitario Clínico San CarlosHospital Da Costa de BurelaHospital del MarHospital Universitario Virgen MacarenaHospital Universitario Infanta Sofía, San Sebastián de los ReyesHospital Universitari Josep Trueta y Hospital Santa CaterinaHospital General Universitario de ElcheFundación Hospital de AlcorcónHospital de Tortosa Verge de la Cinta (HTVC)Complejo Asistencial Universitario de BurgosUnidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica. Hospital Universitario de CanariasHospital Ramón y CajalHospital Universitario Puerta de HierroHospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo (CHUVI)Servicio de Neurología, Complejo Hospitalario Universitario de ToledoComplejo Hospitalario de NavarraHospital Universitario Central de AsturiasComplejo Hospitalario Universitario de Pontevedra (CHOP)Hospital Universitario DonostiaServicio de Neurología, Hospital Arnau de VilanovaHospital Ruber InternacionalNeurology Department and Neurodegenerative Diseases Research GroupHospital Lucus AugustiHospital Rey Juan CarlosCentro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED)Centro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED)Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant PauAbstract Background Identifying modifiable risk factors for cognitive impairment in the early stages of Parkinson’s disease (PD) and estimating their impact on cognitive status may help prevent dementia (PDD) and the design of cognitive trials. Methods Using a standard approach for the assessment of global cognition in PD and controlling for the effects of age, education and disease duration, we explored the associations between cognitive status, comorbidities, metabolic variables and lifestyle variables in 533 PD participants from the COPPADIS study. Results Among the overall sample, 21% of participants were classified as PD-MCI (n = 114) and 4% as PDD (n = 26). The prevalence of hypertension, diabetes and dyslipidemia was significantly higher in cognitively impaired patients while no between-group differences were found for smoking, alcohol intake or use of supplementary vitamins. Better cognitive scores were significantly associated with regular physical exercise (p < 0.05) and cognitive stimulation (< 0.01). Cognitive performance was negatively associated with interleukin 2 (Il2) (p < 0.05), Il6 (p < 0.05), iron (p < 0.05), and homocysteine (p < 0.005) levels, and positively associated with vitamin B12 levels (p < 0.005). Conclusions We extend previous findings regarding the positive and negative influence of various comorbidities and lifestyle factors on cognitive status in early PD patients, and reinforce the need to identify and treat potentially modifiable variables with the intention of exploring the possible improvement of the global cognitive status of patients with PD.https://doi.org/10.1186/s12883-021-02485-1Parkinson’s diseasePD-MCICognitionLifestyleCoppadis
spellingShingle Saul Martínez-Horta
Helena Bejr-Kasem
Andrea Horta-Barba
Berta Pascual-Sedano
Diego Santos-García
Teresa de Deus-Fonticoba
Silvia Jesús
Miquel Aguilar
Lluis Planellas
Juan García-Caldentey
Nuria Caballol
Bárbara Vives-Pastor
Jorge Hernández-Vara
Iria Cabo-Lopez
Lydia López-Manzanares
Isabel González-Aramburu
Maria Asunción Ávila-Rivera
Maria Jose Catalán
Luis Manuel López-Díaz
Victor Puente
Jose Manuel García-Moreno
Carmen Borrué
Berta Solano-Vila
Maria Álvarez-Sauco
Lydia Vela
Sonia Escalante
Esther Cubo
Francisco Carrillo-Padilla
Juan Carlos Martínez-Castrillo
Pilar Sánchez-Alonso
Maria Gema Alonso-Losada
Nuria López-Ariztegui
Itziar Gastón
Marta Blázquez-Estrada
Manual Seijo-Martínez
Javier Rúiz-Martínez
Caridad Valero-Merino
Monica Kurtis
Oriol de Fábregues-Boixar
Jessica González-Ardura
Cristina Prieto-Jurczynska
Pablo Martinez-Martin
Pablo Mir
Jaime Kulisevsky
COPPADIS Study Group
Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease
BMC Neurology
Parkinson’s disease
PD-MCI
Cognition
Lifestyle
Coppadis
title Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease
title_full Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease
title_fullStr Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease
title_full_unstemmed Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease
title_short Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease
title_sort identifying comorbidities and lifestyle factors contributing to the cognitive profile of early parkinson s disease
topic Parkinson’s disease
PD-MCI
Cognition
Lifestyle
Coppadis
url https://doi.org/10.1186/s12883-021-02485-1
work_keys_str_mv AT saulmartinezhorta identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT helenabejrkasem identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT andreahortabarba identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT bertapascualsedano identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT diegosantosgarcia identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT teresadedeusfonticoba identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT silviajesus identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT miquelaguilar identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT lluisplanellas identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT juangarciacaldentey identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT nuriacaballol identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT barbaravivespastor identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT jorgehernandezvara identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT iriacabolopez identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT lydialopezmanzanares identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT isabelgonzalezaramburu identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT mariaasuncionavilarivera identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT mariajosecatalan identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT luismanuellopezdiaz identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT victorpuente identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT josemanuelgarciamoreno identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT carmenborrue identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT bertasolanovila identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT mariaalvarezsauco identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT lydiavela identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT soniaescalante identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT esthercubo identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT franciscocarrillopadilla identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT juancarlosmartinezcastrillo identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT pilarsanchezalonso identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT mariagemaalonsolosada identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT nurialopezariztegui identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT itziargaston identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT martablazquezestrada identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT manualseijomartinez identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT javierruizmartinez identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT caridadvaleromerino identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT monicakurtis identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT orioldefabreguesboixar identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT jessicagonzalezardura identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT cristinaprietojurczynska identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT pablomartinezmartin identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT pablomir identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT jaimekulisevsky identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease
AT coppadisstudygroup identifyingcomorbiditiesandlifestylefactorscontributingtothecognitiveprofileofearlyparkinsonsdisease